CSIMarket
 

Luminex Corporation  (LMNX)
Other Ticker:  
 

Luminex's Working Capital Per Sales

LMNX's Working Capital and Revenue growth



LMNX Working Capital Per Revenue (Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Jun 30 2020)
II. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
Y / Y Working Capital Change - 184.62 % 165.16 % -4.6 % -34.46 %
Y / Y Revenue Change 40.69 % 75.96 % 32.9 % 11.55 % 8.6 %
Working Capital Per Revenue - 0.65 0.57 0.44 0.45
Total Ranking # # # # #
Seq. Working Capital Change - 7.5 % 171.58 % 1.41 % -3.86 %
Seq. Revenue Change -24.26 % 33.45 % 21.01 % 15.03 % -5.28 %





Comment on LMNX's Working Capital Per Revenue in the first quarter 2021
Luminex's Working Capital Per Revenue in the Q1 2021 sequentially fell to 0.52 but remained above Luminex's average.

Within Healthcare sector Luminex Corporation has achieved the lowest Working Capital Per Revenue. While Working Capital Per Revenue remained unchanged in the Q1 2021 relative to the prior quarter at no. .
Working Capital Per Revenue Ranking
Within: No.
Industry #
Sector #
S&P 500 #


Working Capital Per Revenue Statistics
High Average Low
0
0
0
 



Financial Statements
Luminex's Working Capital $ 0 Millions Visit LMNX's Balance sheet
Luminex's Revenues $ 111 Millions Visit LMNX's Income Statement
Where are LMNX's Sales coming from? Visit LMNX's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Mar 31 2021, within Healthcare Sector Working Capital Per Revenue
Repligen Corp  1.43 
Amicus Therapeutics inc   1.43 
Myomo Inc   1.41 
Natera inc   1.39 
Nevro Corp   1.38 
Eton Pharmaceuticals Inc   1.37 
Vyant Bio Inc   1.36 
Dexcom Inc   1.36 
Stereotaxis Inc   1.35 
Acadia Pharmaceuticals Inc   1.34 
Opiant Pharmaceuticals Inc   1.34 
Vanda Pharmaceuticals Inc   1.33 
Utah Medical Products Inc  1.33 
Innoviva Inc   1.29 
Therapeuticsmd Inc   1.28 
Glaukos Corp  1.28 
Invitae Corporation  1.27 
Adamas Pharmaceuticals Inc  1.26 
Nephros Inc   1.25 
Anika Therapeutics Inc   1.22 
Intersect Ent Inc   1.22 
Establishment Labs Holdings Inc   1.21 
Sage Therapeutics Inc   1.21 
Intercept Pharmaceuticals inc   1.20 
Coherus Biosciences inc   1.20 
Exelixis Inc   1.19 
Corcept Therapeutics Inc  1.19 
Atricure Inc   1.18 
Novocure Limited  1.18 
Intuitive Surgical Inc   1.16 
Date modified: -0001-11-30T00:00:00+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com